Affimed Therapeutics AG expands clinical development team
Christian Hucke has long-term experience in conception and management of clinical studies. At Grünenthal he had the overall responsibility for a worldwide Phase-III-Study in pain therapy of cancer patients as well as a Proof-of-Concept-Phase-II-Study against diabetic polyneuropathy. Previously, Dr Hucke worked in clinical drug development at PAION Deutschland GmbH and the ClinPharmCologne TROPON GmbH. In the course of his various activities he was responsible for more than 12 Phase-I, II- and III-Studies in diverse indications. Christian Hucke is a doctor in biology with focus on immunology. After graduating and obtaining a doctorate degree in Düsseldorf he worked at the institute of Medical Microbiology at the Heinrich-Heine University of Düsseldorf.
Dr Rolf H. Günther, CEO of Affimed, commented: "The year 2010 will be a very important and decisive year for Affimed: both our lead-products will enter the clinic in 2010. In this crucial phase, Christian Hucke will hold a key position in our development team."
Most read news
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.